SCHEMBL1808108

SCHEMBL1808108

O=C(NC(Cl)Cc1ccccc1)c1noc2c1CCc1cc(COC(=O)C3CNC3)ccc1-2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 9/20 0.45
HSD17B10 Q99714 7/20 0.45
MAPK1 P28482 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
SMN1; SMN2 Q16637 8/20 0.45
NPC1 O15118 7/20 0.45
TP53 P04637 5/20 0.45
HTT P42858 3/20 0.45
MAPT P10636 9/20 0.44
ALDH1A1 P00352 3/20 0.44
HPGD P15428 2/20 0.43
SMURF2 Q9HAU4 3/20 0.43
SMURF1 Q9HCE7 3/20 0.43
LMNA P02545 3/20 0.43
NPSR1 Q6W5P4 1/20 0.43
KDM4E B2RXH2 3/20 0.42
TSHR P16473 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11971366 0.81 S1PR1 (0.57) SMURF2SMURF1
SCHEMBL1805574 0.72 S1PR1 (0.63) RAB9AHSD17B10CYP1A2CYP2D6SMN1; SMN2
SCHEMBL1814499 0.67 RAB9A (0.67) RAB9AHSD17B10MAPK1CYP1A2CYP2D6
SCHEMBL1812390 0.66 S1PR1 (0.61) RAB9AHSD17B10MAPK1CYP1A2CYP2D6
SCHEMBL1816395 0.66 S1PR1 (0.57) RAB9AHSD17B10MAPK1CYP1A2CYP2D6
SCHEMBL1814756 0.65 S1PR1 (0.57) RAB9ASMN1; SMN2NPC1HTTMAPT
SCHEMBL1816689 0.65 S1PR1 (0.57) RAB9AHSD17B10MAPK1CYP1A2CYP2D6
SCHEMBL5220501 0.65 HTR2C (0.57) RAB9AMAPK1CYP2C19SMN1; SMN2NPC1
SCHEMBL17261642 0.64 SMURF2 (0.59) RAB9AHSD17B10MAPK1CYP1A2CYP2D6
SCHEMBL1815111 0.64 ALDH1A1 (0.66) HSD17B10SMN1; SMN2TP53HTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2493866-A1 TRICYCLIC HETEROCYCLIC COMPOUNDS Bristol-Myers Squibb Company (US) 2012-09-05 EP disclosed
WO-2011059784-A1 TRICYCLIC HETEROCYCLIC COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2011-05-19 WO disclosed